Brief: Sol-Gel And Searchlight Pharma Announce Licensing Agreements To Commercialize TWYNEO And EPSOLAY In Canada

SOL-GEL TECHNOLOGIES

06/06/2023 12:15

June 6 (Reuters) - Sol Gel Technologies Ltd  SLGL.O :
    * SOL-GEL AND SEARCHLIGHT PHARMA ANNOUNCE LICENSING
AGREEMENTS TO
COMMERCIALIZE TWYNEO® AND EPSOLAY® IN CANADA
    * SOL GEL TECHNOLOGIES - TO GET UP TO $11 MILLION IN UPFRONT
PAYMENTS, MILESTONES FOR BOTH DRUGS, COMBINED
    * SOL GEL TECHNOLOGIES LTD - WILL BE ENTITLED TO ROYALTY
PERCENTAGES OF ALL CANADIAN NET SALES RANGING FROM
LOW-DOUBLE-DIGITS TO HIGH TEENS

Source text for Eikon:  ID:nGNX3gCbJP 
Further company coverage:  SLGL.O